Search this website. You can use fund codes to locate specific funds

Investor expectations for global plastics challenges

EOS publishes new Investor Expectations for Global Plastics Challenges

Fast reading

  • Companies reliant on the take-make-waste model will face substantial commercial risks in coming years

  • In 2020 and beyond, we are amplifying our engagement in the chemicals, consumer goods and retail sectors

  • Our report concludes with a series of questions that investors can put to companies

Investors are concerned that a failure to account for the negative impacts of plastic has resulted in numerous interlinked challenges – from acute environmental pollution and potential human health impacts, to substantial greenhouse gas emissions across plastics value chains. We believe that the linear, take-make-waste model for plastics has become unacceptable and companies reliant on this model will face substantial new commercial risks in coming years.

We expect companies to move from treating plastic as an externalised risk, to developing strategies that consider it as a resource requiring responsible management and value preservation – in partnership with suppliers, customers, processors and regulators.

Our engagement activity focuses on businesses engaged in the manufacturing of chemicals for plastics, and the design, marketing and retailing of consumer goods. In 2020 and beyond, we are amplifying our engagement in the chemicals, consumer goods and retail sectors by setting objectives for high-risk companies and targeting outcomes that address opportunities and risks.

We take a bespoke approach to each company exposed to plastics value chains, which takes the maturity of the company into account. Our approach considers all the elements relating to a sustainable plastics strategy, including the management, governance and disclosure.

For each sector in this report, we believe companies should be on a journey of change. This report concludes with a series of questions that investors can ask companies at each point on this journey. Without a cogent, disclosed journey on the sustainability of plastics and packaging, we believe many companies will face significant scrutiny from investors and stakeholders.

Related Insights

Burberry case study
Burberry has reaffirmed its commitment to find alternatives to incinerating surplus stock in the midst of the coronavirus pandemic and set a science-based carbon reduction target.
The coronavirus and the race for a vaccine
With the coronavirus pandemic set to continue without an effective and widely-available vaccine, all eyes are on the pharmaceutical sector.
Mizuho Financial Group case study
Mizuho has made a commitment to ending financing of new coal-fired power plants and reducing exposure to coal-fired power plants to zero by 2050, the only Japanese bank to makes such a commitment.
A voting season like no other
With many companies opting for virtual shareholder meetings, how did investors ensure their concerns about climate change, diversity and human rights risks were addressed?
Antimicrobial resistance and the challenge for pharmaceutical companies
A lack of research and development into new antibiotic classes compounds the serious threat that antimicrobial resistance poses to public health.
Repsol case study
Repsol became the first oil and gas company to commit to a net-zero goal by 2050, supported by a decarbonisation pathway with interim targets, setting a higher benchmark for the industry. EOS has engaged with the company since 2013 on its climate action and targets.

EOS Client Service and Business Development

Amy D’Eugenio,
Head of Client Service and Business Development, EOS